▶주메뉴 바로가기
▶본문 바로가기
SK Pharmteco, a consolidated global pharmaceuticals manufacturing chain of SK Group, will provide US-based Phlow with pharmaceutical ingredients to offset supply shortfall in the country, SK Holdings...
DongKoo Bio&Pharma said on May 19 that it has expanded its field of business to artificial intelligence by investing 3 billion won ($2.4 million) in medical solution provider Vuno. The two firms sig...
Bill & Melinda Gates Foundation is doling out a series of funding for epidemic countermeasure research in Korea. SK Bioscience, a vaccine researcher and developer firm, said on May 18 that it has na...
Real-time polymerase chain reaction COVID-19 detection test kit maker Seegene saw a whopping 600 percent jump in its consolidated operating profit and net profit in the first quarter of 2020, accordi...
South Korea’s Hanmi Pharmaceutical may consider taking legal action against global biopharma Sanofi as the French company abruptly decided to halt participation in further research on efpeglenatide, ...
The head of local biotechnology firm SillaJen was detained on May 12 for alleged involvement in insider trading, raising market fears over SillaJen’s fate as a Kosdaq-listed company. The Seoul Sout...
Samsung Biologics on April 10 signed a binding letter of intent worth 440 billion won ($363 million) to manufacture US-based Vir’s COVID-19 treatment, starting 2021. It is the biggest single deal S...
The US subsidiary of South Korea’s Lutronic is facing a lawsuit for allegedly misappropriating trade secrets through former employees of Cutera it hired recently, according to documents reviewed by T...
Prosecutors on Jan. 6 raided the headquarters of Kolon Group, as part of their investigations into alleged fraud in the listing of an affiliate involved in the development of the group‘s controversia...
South Korean drugmaker Daewoong Pharmaceutical said Dec. 19 it has won approval from authorities in the United Arab Emirates and Indonesia for the sale of its botulinum toxin product. The Ministr...
Celltrion announced on Dec. 9 that it has disclosed its biosimilar Truxima’s results of phase 3 clinical trial at the 2019 annual meeting of the American Society of Hematology last week. “The clinic...
South Korea’s nonlife insurance firms saw their combined net profit drop 24.6 percent in the first nine months of 2019 from a year earlier, mainly due to increased losses stemming from their long-ter...
SK Chemical on Nov. 27 announced that its SID 710, a patch-type medication that aims to treat people with Alzheimer’s disease has won sales approval from the US Food and Drug Administration. The pat...
South Korean biopharmaceutical firm Celltrion said Nov. 26 that its drug Remsima SC for the treatment of autoimmune diseases has won sales approval in Europe. The European Medicines Agency has gi...
South Korean drug firm SK Biopharmaceuticals is expected to raise at least 5 trillion won ($4.25 billion) through a planned share sale, analysts said Nov. 25. The company said that XCOPRI has won...
[Herald Interview] NYSE hopes to see more Korean firms listing in US
Watchdog orders banks to compensate investors for damages from Lime misselling
National Pension Service gains W72tr for 2020
Provisioning, relief measures to support S. Korean banks’ performance: Fitch
Once-hot P2P lending industry faces tough road ahead
SK Bioscience seeks up to W1.5tr in blockbuster IPO
S. Korean unicorns take big leap with greater global presence
[News Focus] Power struggle? FSC, BOK bicker over revision of payment settlement law
February 27, 2021
![[Herald Interview] NYSE hopes to see more Korean firms listing in US](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=151&simg=/content/image/2021/02/26/20210226000217_0.jpg&md=20210226125435)
![[News Focus] Power struggle? FSC, BOK bicker over revision of payment settlement law](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=151&simg=/content/image/2021/02/22/20210222000835_0.jpg&md=20210222175948)
